EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Hederagenin’s uric acid-lowering effects in hyperuricemic mice: Mechanistic insights from molecular docking and in vivo analysis

Ping Chen, Ya-Ni Tian, Jing-Tao Wang, Xiang-Lin Yin, Bao-Sheng Guan, Xue Bai iD

PLOS One · 2025

DOI: 10.1371/journal.pone.0326317 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS One, 2025. Verfasst von Ping Chen und 5 weiteren Autor:innen. Beteiligte Einrichtung: School of Clinical Medicine, Jiamusi University, Jiamusi, China. Hauptthemen laut MEDLINE: Hyperuricemia, Uric Acid, Oleanolic Acid. Die Arbeit nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Heilongjiang Province Natural Science Foundation Outstanding Youth Project.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This study explored the uric acid-lowering effects of hederagenin (HD) through molecular docking analysis and a chronic hyperuricemia (HUA) mouse model. Molecular docking was performed to evaluate HD’s interactions key urate-regulating proteins, including xanthine oxidase (XOD), ABCG2, OAT1, URAT1, and GLUT9. To establish a chronic HUA model, mice were fed a yeast-adenine diet supplemented with potassium oxonate. The mice were randomly assigned to six groups: normal control, HUA model control, benzbromarone (BEN) group, and three HD treatment groups at doses of 50, 100, and 200 mg/kg. Serum uric acid (UA) levels, liver and kidney function indicators, XOD activity, and oxidative stress markers were assessed. Histopathological analyses of the liver and kidney were also conducted. In addition, gene and protein expression levels of urate transporters and inflammatory markers were assessed using RT-PCR and Western blotting. The results showed that HD interacts with XOD and urate transporters, significantly reducing serum UA levels and inhibiting XOD activity in HUA model. It also modulated the expression of urate transporter to enhance UA excretion. Moreover, HD protected liver and kidney function by reducing pro-inflammatory cytokine levels and inhibiting the TLR4/Myd88/NF-κB and NLRP3 signaling pathways. These findings suggest HD may serve as a promising therapeutic agent for lowing uric acid and preventing organ damage associated with HUA.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HyperuricemiaUric AcidOleanolic AcidAnimalsMolecular Docking SimulationMiceXanthine OxidaseMaleKidneyOrganic Anion TransportersLiverDisease Models, AnimalATP Binding Cassette Transporter, Subfamily G, Member 2Oxidative StressOrganic Anion Transport Protein 1Glucose Transport Proteins, FacilitativeNF-kappa BNLR Family, Pyrin Domain-Containing 3 Protein

Substanzen

Uric AcidXanthine OxidaseOleanolic AcidhederageninOrganic Anion TransportersATP Binding Cassette Transporter, Subfamily G, Member 2Slc22a12 protein, mouseSlc2a9 protein, mouseOrganic Anion Transport Protein 1Glucose Transport Proteins, Facilitative

Autor:innen und Institutionen

  • School of Clinical Medicine, Jiamusi University, Jiamusi, China.
  • School of Basic Medicine, Jiamusi University, Jiamusi, China.
  • School of Public Health, Jiamusi University, Jiamusi, China.
  • Heilongjiang Key Laboratory of Gout Research, Jiamusi University, Jiamusi, China.
  • Department of Pharmacy, The Second Affiliated Hospital of Harbin Medical University, Harbin, China.

ORCID-Profile: Xue Bai

Förderung

  • Heilongjiang Province Natural Science Foundation Outstanding Youth Project

Zitieren

APA

Chen, P., Tian, Y. N., Wang, J. T., Yin, X. L., Guan, B. S., & Bai, X. (2025). Hederagenin’s uric acid-lowering effects in hyperuricemic mice: Mechanistic insights from molecular docking and in vivo analysis. PLOS One. https://doi.org/10.1371/journal.pone.0326317

Vancouver

Chen P, Tian YN, Wang JT, Yin XL, Guan BS, Bai X. Hederagenin’s uric acid-lowering effects in hyperuricemic mice: Mechanistic insights from molecular docking and in vivo analysis. PLOS One. 2025. doi:10.1371/journal.pone.0326317

BibTeX
@article{Chen2025,
  author = {Chen, Ping and Tian, Ya-Ni and Wang, Jing-Tao and Yin, Xiang-Lin and Guan, Bao-Sheng and Bai, Xue},
  title = {Hederagenin’s uric acid-lowering effects in hyperuricemic mice: Mechanistic insights from molecular docking and in vivo analysis},
  journal = {PLOS One},
  year = {2025},
  doi = {10.1371/journal.pone.0326317}
}
Kostenlos starten →